CARL L GORDON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CARL L GORDON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARL L GORDON. CARL L GORDON is a Director in SELECTA BIOSCIENCES INC ($SELB) and a Director in Arsanis, Inc. ($ASNS) and a Director in Turning Point Therapeutics, Inc. ($TPTX) and a Director in Intellia Therapeutics, Inc. ($NTLA) and a Director in Alector, Inc. ($ALEC) and a Director in Keros Therapeutics, Inc. ($KROS) and a Director in ARMO BioSciences, Inc. ($ARMO) and a Director in Adicet Bio, Inc. ($TORC) and a Director in Prevail Therapeutics Inc. ($PRVL) and a in Kinnate Biopharma Inc. ($KNTE) and a Director in Oric Pharmaceuticals, Inc. ($ORIC) and a Director in Terns Pharmaceuticals, Inc. ($TERN).
Address: 767 THIRD AVENUE 30TH FLOOR NEW YORK 10010 NY
Companies in which CARL L GORDON is an Insider
Adicet Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL L GORDON: Director
Holdings: 5,243,259 shares
Latest Transaction: May 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Alector, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CARL L GORDON: Director
Holdings: 405,925 shares
Latest Transaction: May 14 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARMO BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL L GORDON: Director
Holdings: 0 shares
Latest Transaction: Jun 22 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of CARL L GORDON: Director
Holdings: 2,662,180 shares
Current Value: $35,406,994
Latest Transaction: May 19 2017
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Keros Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL L GORDON: Director
Holdings: 744,612 shares
Latest Transaction: Apr 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kinnate Biopharma Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL L GORDON:
Holdings: 543,494 shares
Latest Transaction: Dec 09 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oric Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL L GORDON: Director
Holdings: 2,240,440 shares
Latest Transaction: Mar 31 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prevail Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CARL L GORDON: Director
Holdings: 0 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SELECTA BIOSCIENCES INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL L GORDON: Director
Holdings: 12,193 shares
Latest Transaction: Jun 29 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Terns Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL L GORDON: Director
Holdings: 1,326,481 shares
Latest Transaction: Feb 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Turning Point Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL L GORDON: Director
Holdings: 1,120,730 shares
Latest Transaction: Jun 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
X4 Pharmaceuticals, Inc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CARL L GORDON: Director
Holdings: 19,533 shares
Latest Transaction: Jun 07 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CARL L GORDON
Sentiment: All, TORC, ALEC, ARMO, NTLA, KROS, KNTE, ORIC, PRVL, SELB, TERN, TPTX, ASNS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Option Exercise | A | 15.93 | 18,500 | 294,705 | 18,500 | |
| Mar 31 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.93 | 27,869 | 666,905 | 2,212,571 | 2.2 M to 2.2 M (-1.24 %) |
| Mar 31 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.31 | 75,555 | 1,761,187 | 2,240,440 | 2.3 M to 2.2 M (-3.26 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |